P19 H-ras induces G1/S phase delay maintaining cells in a reversible quiescence state

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Camats, Maria ^a   Kokolo, Mariette ^a   Heesom, Kate J ^b   Ladomery, Michael ^c   Bach Elias, Montse ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN P19; PROTEIN P21; PROTEIN P73; RAS PROTEIN; S6 KINASE; TELOMERASE; TRANSCRIPTION FACTOR FKHR; TUBERIN; DNA BINDING PROTEIN; HRAS PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR PROTEIN; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL QUIESCENCE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEOMICS; UPREGULATION; CELL PROLIFERATION; CHEMISTRY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE;

MAMMALIA;

BASE SEQUENCE; CELL PROLIFERATION; DNA-BINDING PROTEINS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTEOMICS; PROTO-ONCOGENE PROTEINS P21(RAS); RNA INTERFERENCE; S PHASE; SRC-FAMILY KINASES; TELOMERASE; TUMOR SUPPRESSOR PROTEINS;

EID: 77949512738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008513     Document Type: Article

References (35)

1. Reuther GW, Der CJ (2000) The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr Opin Cell Biol 12: 157-165.
2. Barbacid M (1987) ras genes. Annu Rev Biochem 56: 779-827.
3. Malumbres M, Pellicer A (1998) RAS pathways to cell cycle control and cell transformation. Front Biosci 3: d887-912.
4. Gripp KW, Stabley DL, Nicholson L, Hoffman JD, Sol-Church K (2006) Somatic mosaicism for an HRAS mutation causes Costello syndrome. Am J Med Genet A 140: 2163-2169.
5. Dereure O (2006) [Mutations in H-Ras proto-oncogen in Costello syndrome]. Ann Dermatol Venereol 133: 731.
6. Esteban LM, Vicario-Abejon C, Fernandez-Salguero P, Fernandez-Medarde A, Swaminathan N, et al. (2001) Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol 21: 1444-1452.
7. Pells S, Divjak M, Romanowski P, Impey H, Hawkins NJ, et al. (1997) Developmentally-regulated expression of murine K-ras isoforms. Oncogene 15: 1781-1786.
8. McGrath JP, Capon DJ, Smith DH, Chen EY, Seeburg PH, et al. (1983) Structure and organization of the human Ki-ras proto oncogene and a related processed pseudogene. Nature 304: 501-506.
9. Cohen JB, Broz SD, Levinson AD (1989) Expression of the H-ras proto- oncogene is controlled by alternative splicing. Cell 58: 461-472.
10. Guil S, Gattoni R, Carrascal M, Abián J, Stevenin J, et al. (2003) Roles of hnRNP A1, SR proteins, and p68 Helicase in c-H-ras Alternative Splicing Regulation. Mol Cel Biol 23: 2927-2941.
11. Guil S, de La Iglesia N, Fernandez-Larrea J, Cifuentes D, Ferrer JC, et al. (2003) Alternative splicing of the human proto-oncogene c-H-ras renders a new Ras family protein that trafficks to cytoplasm and nucleus. Cancer Res 63: 5178-5187.
12. Schechtman D, Mochly-Rosen D (2001) Adaptor proteins in protein kinase C mediated signal transduction. Oncogene 20: 6339-6347.
13. Sklan EH, Podoly E, Soreq H (2006) RACK1 has the nerve to act: structure meets function in the nervous system. Prog Neurobiol 78: 117-134.
14. Jeong MH, Bae J, Kim WH, Yoo SM, Kim JW, et al. (2006) p19ras interacts with and activates p73 by involving the MDM2 protein. J Biol Chem 281: 8707-8715.
15. Bhaskar PT, Hay N (2007) The two TORCs and Akt. Dev Cell 12: 487-502.
16. Hsu YC, Chern JJ, Cai Y, Liu M, Choi KW (2007) Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature 445: 785-788.
17. Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, et al. (2005) RACK1 mediates activation of JNK by protein kinase C. Mol Cell 19: 309-320.
18. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, et al. (1996) Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 271: 23512-23519.
19. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, et al. (2006) ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 5: 14.
20. Villanueva J, Yung Y, Walker JL, Assoian RK (2007) ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. Mol Biol Cell 18: 1457-1463.
21. Mamidipudi V, Zhang J, Lee KC, Cartwright CA (2004) RACK1 regulates G1/ S progression by suppressing Src kinase activity. Mol Cell Biol 24: 6788-6798.
22. Marabese M, Vikhanskaya F, Broggini M (2007) p73: A chiaroscuro gene in cancer. Eur J Cancer 43: 1361-1372.
23. Toh WH, Kyo S, Sabapathy K (2005) Relief of p53-mediated telomerase suppression by p73. J Biol Chem 280: 17329-17338.
24. Tanno T, Fujiwara A, Sakaguchi K, Tanaka K, Takenaka S, et al. (2007) Slit3 regulates cell motility through Rac/Cdc42 activation in lipopolysaccharide stimulated macrophages. FEBS Lett 581: 1022-1026.
25. Mathas S, Hinz M, Anagnostopoulos I, Krappmann D, Lietz A, et al. (2002) Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. Embo J 21: 4104-4113.
26. Rangatia J, Vangala RK, Singh SM, Peer Zada AA, Elsasser A, et al. (2003) Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction. Oncogene 22: 4760-4764.
27. Taub J, Lau JF, Ma C, Hahn JH, Hoque R, et al. (2003) A cytosolic catalase is needed to extend adult lifespan in C. elegans daf-C and clk-1 mutants. Nature 421: 764.
28. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, et al. (2002) Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316-321.
29. Rahman-Roblick R, Roblick UJ, Hellman U, Conrotto P, Liu T, et al. (2007) p53 targets identified by protein expression profiling. Proc Natl Acad Sci U S A 104: 5401-5406.
30. Kohno M, Pouyssegur J (2006) Targeting the ERK signaling pathway in cancer therapy. Ann Med 38: 200-211.
31. Tran H, Brunet A, Grenier JM, Datta SR, Fornace AJ, Jr., et al. (2002) DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296: 530-534.
32. Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, et al. (2002) Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 22: 2025-2036.
33. Cai D, McCarron RM, Yu EZ, Li Y, Hallenbeck J (2004) Akt phosphorylation and kinase activity are down-regulated during hibernation in the 13-lined ground squirrel. Brain Res 1014: 14-21.
34. Kim JW, Kim WH, Jeong MH, Jang SM, Song KH, et al. (2008) p19(ras) amplifies p73beta-induced apoptosis through mitochondrial pathway. Biochem Biophys Res Commun 373: 146-150.
35. Gray JV, Petsko GA, Johnston GC, Ringe D, Singer RA, et al. (2004) 'Sleeping beauty': quiescence in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 68: 187-206.